Evolución de sus características en 15 años | 11 FEB 13

Bacteriemia adquirida en la comunidad en pacientes críticamente enfermos

Un análisis de los cambios en la prevalencia, las características clínicas y la evolución de pacientes críticamente enfermos con bacteriemia adquirida en la comunidad en los últimos 15 años.
Autor/a: Dres. Jordi Vallés, Mercedes Palomar, Francisco Alvárez-Lerma, Jordi Rello, Armando Blanco, José Garnacho-Montero, Ignacio Martín-Loeches Crit Care Med 2013; 41:76–83)
INDICE:  1. Artículo | 2. Referencias
Referencias

1. Hugonnet S, Harbarth S, Ferrière K, et al: Bacteremic sepsis in intensive care: Temporal trends in incidence, organ dysfunction, and prognosis.Crit Care Med 2003; 31:390–394
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303–1310
3. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244–1250
4. Vallés J, Rello J, Ochagavía A, et al; Community-acquired bloodstream infection in critically ill adult patients: Impact of shock and inappropriate antibiotic therapy on survival. Chest 2013; 123:1615–1624
5. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818–829
6. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644–1655
7. Kollef MH: Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31 Suppl 4:S131–S138
8. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546–1554
9. Valles, Alvarez-Lerma F, Palomar M, et al: Health-care-associated bloodstream infections at admission to the ICU. Chest 2011; 139:810–815
10. Fisher LD, Van Belle G (Eds): Biostatistics: A Methodology for the Health Sciences. New York, John Wiley & Sons, 1993
11. Hosmer DW Jr, Lemeshow S (Eds): Applied Logistic Regression. New York, John Wiley & Sons, 1989
12. Flaaten H: Epidemiology of sepsis in Norway in 1999. Crit Care 2004; 8:R180–R184
13. Esteban A, Frutos-Vivar F, Ferguson ND, et al: Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007; 35:1284–1289
14. Annane D, Aegerter P, Jars-Guincestre MC, et al; CUB-Réa Network: Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med 2003; 168:165–172
15. Azoulay E, Soares M, Darmon M, et al: Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 2011; 1:5
16. Larché J, Azoulay E, Fieux F, et al: Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003; 29:1688–1695
17. Vincent JL, Rello J, Marshall J, et al; EPIC II Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323–2329
18. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368–1377
19. Houck PM, Bratzler DW, Nsa W, et al: Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637–644
20. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589–1596
21. Dellinger RP, Carlet JM, Masur H, et al; Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858–873
22. Ferrer R, Artigas A, Suarez D, et al; Edusepsis Study Group: Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009; 180:861–866
23. Søgaard M, Schønheyder HC, Riis A, et al: Short-term mortality in relation to age and comorbidity in older adults with communityacquired bacteremia: a population-based cohort study. J Am Geriatr Soc 2008; 56:1593 1600

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2021